Clearside Biomedical, Inc. Profile Avatar - Palmy Investing

Clearside Biomedical, Inc.

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable susp…

Biotechnology
US, Alpharetta [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of CLSD's Analysis
CIK: 1539029 CUSIP: 185063104 ISIN: US1850631045 LEI: - UEI: -
Secondary Listings
CLSD has no secondary listings inside our databases.